Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Angioedema”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Post-approval studies (Phase 4)Study completedNCT02966314
What this trial is testing

Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy

Who this might be right for
Idiopathic Angioedema
University of Wisconsin, Madison 12
Not applicableUnknownNCT00163839
What this trial is testing

The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema

Who this might be right for
UrticariaAngioedema
Bayside Health 50
Large-scale testing (Phase 3)Study completedNCT02161562
What this trial is testing

OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 314
Testing effectiveness (Phase 2)Study completedNCT00890162
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

Who this might be right for
AnaphylaxisHypotensionBronchospasm+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 16
Not applicableEnded earlyNCT02892682
What this trial is testing

The Role of the Coagulation Pathways in Recurrent Angioedema

Who this might be right for
Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency
University Hospital, Montpellier 96
Testing effectiveness (Phase 2)Study completedNCT05936567
What this trial is testing

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

Who this might be right for
UrticariaChronic Spontaneous UrticariaChronic Idiopathic Urticaria+3 more
Incyte Corporation 136